Sodanin Saing

Sodanin Saing

Active Director Designated Partner DIN 08042151
DIN 08042151 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sodanin Saing

Data last updated:

Sodanin Saing is a Designated Partner at Curventis Laboratories Llp (since 2018). The company operates in Pharma.

DIN 08042151
Primary Designation Designated Partner
Industry Pharma
First Appointment 26 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Feb 20182018Active

Board colleagues of Sodanin Saing

NameDINCompanyDesignation
Hemin Bhaskarbhai Patel06559322Curventis Laboratories LlpDesignated Partner
Mahipat Ambalalbhai Patel06373494Curventis Laboratories LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curventis Laboratories Llp
Premium access

Shareholding and investment profile for Sodanin Saing

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sodanin Saing

Sodanin Saing currently holds 1 directorship: Curventis Laboratories Llp (Designated Partner, since 26 Feb 2018).

Sodanin Saing was first appointed on 26 Feb 2018 as Designated Partner at Curventis Laboratories Llp.

The current boards of Sodanin Saing's companies include Hemin Bhaskarbhai Patel (Curventis Laboratories Llp), Mahipat Ambalalbhai Patel (Curventis Laboratories Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available